Works matching IS 20734468 AND DT 2024 AND VI 13 AND IP 3
Results: 29
SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 78, doi. 10.3390/antib13030078
- By:
- Publication type:
- Article
Residue-Specific Epitope Mapping of the PD-1/Nivolumab Interaction Using X-ray Footprinting Mass Spectrometry.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 77, doi. 10.3390/antib13030077
- By:
- Publication type:
- Article
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 76, doi. 10.3390/antib13030076
- By:
- Publication type:
- Article
A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 75, doi. 10.3390/antib13030075
- By:
- Publication type:
- Article
The Accurate Prediction of Antibody Deamidations by Combining High-Throughput Automated Peptide Mapping and Protein Language Model-Based Deep Learning.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 74, doi. 10.3390/antib13030074
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Infliximab and Adalimumab through Concentration and Anti-Drug Antibodies Assessment; Comparison of Sanquin Diagnostics and Theradiag Assays.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 73, doi. 10.3390/antib13030073
- By:
- Publication type:
- Article
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 72, doi. 10.3390/antib13030072
- By:
- Publication type:
- Article
Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 71, doi. 10.3390/antib13030071
- By:
- Publication type:
- Article
A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 70, doi. 10.3390/antib13030070
- By:
- Publication type:
- Article
Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax : Follow-Up Study.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 69, doi. 10.3390/antib13030069
- By:
- Publication type:
- Article
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 63, doi. 10.3390/antib13030063
- By:
- Publication type:
- Article
Identification of Conserved Linear Epitopes on Viral Protein 2 of Foot-and-Mouth Disease Virus Serotype O by Monoclonal Antibodies 6F4.D11.B6 and 8D6.B9.C3.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 67, doi. 10.3390/antib13030067
- By:
- Publication type:
- Article
Enhanced N-Glycan Profiling of Therapeutic Monoclonal Antibodies through the Application of Upper-Hinge Middle-Up Level LC-HRMS Analysis.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 66, doi. 10.3390/antib13030066
- By:
- Publication type:
- Article
The Seraph 100 ® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 65, doi. 10.3390/antib13030065
- By:
- Publication type:
- Article
Prevention of Blood Incompatibility Related Hemagglutination: Blocking of Antigen A on Red Blood Cells Using In Silico Designed Recombinant Anti-A scFv.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 64, doi. 10.3390/antib13030064
- By:
- Publication type:
- Article
Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 68, doi. 10.3390/antib13030068
- By:
- Publication type:
- Article
Novel Flow Cytometry Method Detecting Complement C1q Bound to Blood Type A/B IgG Antibody for Preventing Severe Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 62, doi. 10.3390/antib13030062
- By:
- Publication type:
- Article
Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 61, doi. 10.3390/antib13030061
- By:
- Publication type:
- Article
Application of Monoclonal Antibodies against Naturally Occurring Bioactive Ingredients.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 60, doi. 10.3390/antib13030060
- By:
- Publication type:
- Article
Adverse Events of PD-1, PD-L1, CTLA-4, and LAG-3 Immune Checkpoint Inhibitors: An Analysis of the FDA Adverse Events Database.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 59, doi. 10.3390/antib13030059
- By:
- Publication type:
- Article
A Comparison of Natural and Therapeutic Anti-IgE Antibodies.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 58, doi. 10.3390/antib13030058
- By:
- Publication type:
- Article
Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 57, doi. 10.3390/antib13030057
- By:
- Publication type:
- Article
Immune-Related Adverse Events Associated with Atezolizumab: Insights from Real-World Pharmacovigilance Data.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 56, doi. 10.3390/antib13030056
- By:
- Publication type:
- Article
NK Cytotoxicity Mediated by NK-92 Cell Lines Expressing Combinations of Two Allelic Variants for FCGR3.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 55, doi. 10.3390/antib13030055
- By:
- Publication type:
- Article
Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 54, doi. 10.3390/antib13030054
- By:
- Publication type:
- Article
A Bead-Based Nonradioactive Immunoassay for Autoantibody Testing in a Mouse Model of Myasthenia Gravis.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 53, doi. 10.3390/antib13030053
- By:
- Publication type:
- Article
Characterization of the Charge Heterogeneity of a Monoclonal Antibody That Binds to Both Cation Exchange and Anion Exchange Columns under the Same Binding Conditions.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 52, doi. 10.3390/antib13030052
- By:
- Publication type:
- Article
177 Lu Anti-Angiogenic Radioimmunotherapy Targeting ATP Synthase in Gastric Cancer Model.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 51, doi. 10.3390/antib13030051
- By:
- Publication type:
- Article
Development, Optimization and Evaluation of a Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) Prototype for Detection of Chicken-Based IgY Polyclonal Antibodies against Toxins of D. polylepis Venom.
- Published in:
- Antibodies (2073-4468), 2024, v. 13, n. 3, p. 50, doi. 10.3390/antib13030050
- By:
- Publication type:
- Article